As the COVID-19 pandemic reached over 97 million cases and exceeded 2 million deaths globally only 1 year after its emergence,1 several candidate vaccines have shown promising efficacy and safety profiles, with some already approved for emergency use and rolled out globally.2
No takes yet. Share an insight, caveat, or question.
Copper et al. (2021) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: